VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,734 | +52.7% | 97,624 | +132.9% | 0.00% | 0.0% |
| Q2 2023 | $276,205 | -1.5% | 41,913 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $280,331 | -69.2% | 41,286 | -66.4% | 0.00% | -50.0% |
| Q4 2022 | $909,116 | -2.5% | 123,020 | +30.2% | 0.00% | 0.0% |
| Q3 2022 | $932,000 | +110.9% | 94,481 | +132.3% | 0.00% | +100.0% |
| Q2 2022 | $442,000 | -22.2% | 40,673 | -19.3% | 0.00% | 0.0% |
| Q1 2022 | $568,000 | -56.6% | 50,413 | -39.7% | 0.00% | -50.0% |
| Q4 2021 | $1,310,000 | -29.9% | 83,636 | -23.4% | 0.00% | -33.3% |
| Q3 2021 | $1,869,000 | -31.5% | 109,148 | -14.0% | 0.00% | -40.0% |
| Q2 2021 | $2,727,000 | -16.9% | 126,860 | -42.0% | 0.01% | -16.7% |
| Q1 2021 | $3,282,000 | -14.3% | 218,864 | -24.9% | 0.01% | -25.0% |
| Q4 2020 | $3,830,000 | +11.5% | 291,399 | -18.5% | 0.01% | +14.3% |
| Q3 2020 | $3,434,000 | +104.3% | 357,529 | +139.8% | 0.01% | +75.0% |
| Q2 2020 | $1,681,000 | -42.3% | 149,108 | -48.4% | 0.00% | -50.0% |
| Q1 2020 | $2,913,000 | -41.4% | 289,126 | -4.6% | 0.01% | -11.1% |
| Q4 2019 | $4,972,000 | +48.2% | 303,189 | +21.2% | 0.01% | +28.6% |
| Q3 2019 | $3,355,000 | +36.3% | 250,083 | +45.4% | 0.01% | +40.0% |
| Q2 2019 | $2,461,000 | -7.9% | 172,046 | +20.0% | 0.01% | 0.0% |
| Q1 2019 | $2,673,000 | +34.5% | 143,371 | +86.6% | 0.01% | +25.0% |
| Q4 2018 | $1,987,000 | +111.4% | 76,834 | +87.6% | 0.00% | +100.0% |
| Q3 2018 | $940,000 | +14.9% | 40,946 | -4.6% | 0.00% | 0.0% |
| Q2 2018 | $818,000 | +10.2% | 42,939 | -2.6% | 0.00% | +100.0% |
| Q1 2018 | $742,000 | +743.2% | 44,065 | +665.9% | 0.00% | – |
| Q4 2017 | $88,000 | -66.4% | 5,753 | -60.7% | 0.00% | – |
| Q3 2017 | $262,000 | -82.9% | 14,626 | -84.4% | 0.00% | -100.0% |
| Q2 2017 | $1,532,000 | +143.6% | 93,995 | +109.3% | 0.00% | +200.0% |
| Q1 2017 | $629,000 | -89.8% | 44,910 | -88.3% | 0.00% | -91.7% |
| Q4 2016 | $6,196,000 | – | 384,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |